Skip to search.
 TSX Up 0.11% TSX Ventures Down 0.09%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
82.68 Down 0.83(0.99%) Dec 9, 4:00PM EST
Prev Close:83.51
Open:84.67
Bid:73.00 x 100
Ask:84.00 x 100
1y Target Est:113.89
Beta:1.97916
Earnings Date:Feb 23 - Feb 27 (Est.)
Day's Range:82.58 - 87.52
52wk Range:62.12 - 107.56
Volume:1,843,346
Avg Vol (3m):1,288,120
Market Cap:14.22B
P/E (ttm):N/A
EPS (ttm):-2.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNDown 0.99%14.22B
FOLDUp 0.66%866.77M
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-3.73
Quarterly EPS Est (Dec-16) :-0.38
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback